Moonlake Immunotherapeutics · NASDAQ:MLTX
Lampert Mark N sold 3,750,000 Moonlake Immunotherapeutics shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Lampert Mark N (Director, 10% owner) sold 3,750,000 Moonlake Immunotherapeutics shares at US$16.79 for US$63M, leaving 1,039,238 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 3,750,000 shares
- Price
- US$16.79
- Value
- US$63M
- Holding after
- 1,039,238 shares
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Class A Ordinary Shares, $0.0001 par value | Sale | 1,932,354 | US$16.79 | 8,302,735 | Direct |
| Mar 31, 2026 | Class A Ordinary Shares, $0.0001 par value | Sale | 1,569,116 | US$16.79 | 6,599,722 | Direct |
| Mar 31, 2026 | Class A Ordinary Shares, $0.0001 par value | Sale | 248,530 | US$16.79 | 1,039,238 | Direct |